Listed

ImmunityBio, Inc.: Form 10-Q for the period ended Jun 30, 2015

Filed with the SEC on Sep 10, 2015 and accepted by EDGAR at Sep 9, 2015, 21:07 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-04-01 to 2015-06-30$91.0kus-gaap:Revenues
Revenue6 months2015-01-01 to 2015-06-30$211.0kus-gaap:Revenues
Research and development3 months2015-04-01 to 2015-06-30$1.7mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2015-01-01 to 2015-06-30$2.3mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2015-04-01 to 2015-06-30$82.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2015-01-01 to 2015-06-30$114.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2015-04-01 to 2015-06-30−$84.1mus-gaap:OperatingIncomeLoss
Operating income6 months2015-01-01 to 2015-06-30−$116.2mus-gaap:OperatingIncomeLoss
Income tax6 months2015-01-01 to 2015-06-30$1.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2015-04-01 to 2015-06-30−$84.6mus-gaap:NetIncomeLoss
Net income6 months2015-01-01 to 2015-06-30−$117.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-04-01 to 2015-06-30−$1.29us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2015-01-01 to 2015-06-30−$1.85us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2015-01-01 to 2015-06-30−$10.0mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure6 months2015-01-01 to 2015-06-30$152.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2015-01-01 to 2015-06-30$4.8mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2015-06-30$120.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-06-30$120.9mus-gaap:AssetsCurrent
Total assetsAt period end2015-06-30$132.6mus-gaap:Assets
Total liabilitiesAt period end2015-06-30$6.0mus-gaap:Liabilities
Shareholders' equityAt period end2015-06-30$126.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-15-007836. Last ingested by Listed: Nov 9, 2026, 17:45 ET. Listed shows no prices and gives no investment advice.